Top entities: Abivax, Euronext Paris, United States, France.

What category does this event fall under?

Business — classified as trading halt.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Abivax requested trading halt Euronext Paris · Abivax announced public offering

Is this event still developing?

This is an active story, last updated Jul 01, 2026. Coverage continues to evolve.

Business trading halt

Abivax Euronext Paris Trading Halt

Q: When did this event occur?

First reported Jul 01, 2026; last updated Jul 01, 2026.

Q: What is the market impact?

General. The temporary trading halt of Abivax's shares on Euronext Paris is a procedural step related to its public offering in the United States.

Analysis based on 13 articles · First reported Jul 01, 2026 · Last updated Jul 01, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The temporary trading halt of Abivax's shares on Euronext Paris is a procedural step related to its public offering in the United States. While it causes a temporary disruption for investors on Euronext Paris, the overall market impact is neutral as it facilitates a capital raise for Abivax.

Biotechnology Financial Services

Event Summary

Abivax, a clinical-stage biotechnology company, announced a temporary trading halt of its ordinary shares on Euronext Paris, effective from the market opening at 9:00 a.m. CEST on July 1, 2026. This halt was requested by Abivax to allow for the confirmation of allocations to investors and the announcement of the pricing of its previously announced public offering of American Depositary Shares in the United States. Trading on Euronext Paris is expected to resume on the same day at approximately 3:30 p.m. CEST.

Key Actions

100 Abivax requested trading halt Euronext Paris

90 Abivax announced public offering

Entities Involved

stock

Abivax

Abivax requested a temporary trading halt of its ordinary shares on Euronext Paris to facilitate the pricing and allocation of its public offering of American Depositary Shares in the United States.

Importance 100.0 Sentiment 0.0

exch

Euronext Paris

Euronext Paris is the exchange where Abivax's ordinary shares are traded and where the temporary halt was implemented.

Importance 80.0 Sentiment 0.0

cnt

United States

The United States is the location of Abivax's public offering of American Depositary Shares, which is the reason for the trading halt.

Importance 50.0 Sentiment 0.0

cnt

France

France is the location where Abivax is based and where Euronext Paris operates.

Importance 20.0 Sentiment 0.0

Relationships

Euronext Paris related ↔ United States

Euronext Paris related ↔ France

United States strained allies ↔ France The United States relies on France as a key European defense partner but frequently pressures Paris to align with its ag

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard